Addigrip 2006/2007

Country: Germany

Language: German

Source: BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

Buy It Now

Active ingredient:

Antigene des Influenza-Virus A/New Caledonia/20/99 (H1N1), Stamm A/New Caledonia/20/99 IVR-116; Antigene des Influenza-Virus A/Wisconsin/67/2005 (H3N2), Stamm A/Hiroshima/52/2005 IVR-142; Antigene des Influenza-Virus B/Malaysia/2506/2004, Stamm B/Malaysia/2506/2004

Available from:

MSD Vaccines S.p.A. (8035392)

INN (International Name):

Antigens of the Influenza Virus A/New Caledonia/20/99 (H1N1), strain A/New Caledonia/20/99 IVR-116, antigens of Influenza Virus A/Wisconsin/67/2005 (H3N2), strain A/Hiroshima/52/2005 IVR-142, antigens of Influenza Virus B/Malaysia/2506/2004 strain B/Malaysia/2506/2004

Pharmaceutical form:

Suspension zur Injektion

Composition:

Teil 1 - Suspension zur Injektion; Antigene des Influenza-Virus A/New Caledonia/20/99 (H1N1), Stamm A/New Caledonia/20/99 IVR-116 (31422) 15 µg Hämagglutinin; Antigene des Influenza-Virus A/Wisconsin/67/2005 (H3N2), Stamm A/Hiroshima/52/2005 IVR-142 (35686) 15 µg Hämagglutinin; Antigene des Influenza-Virus B/Malaysia/2506/2004, Stamm B/Malaysia/2506/2004 (35687) 15 µg Hämagglutinin

Administration route:

Injektion intramuskulär

Authorization status:

verlängert

Authorization date:

2000-08-23